Holly Symonds Clark, Ph.D., is the new Senior Commercialization Manager for the Office of Technology Commercialization. She will be managing UK's therapeutics portfolio and work with UK Innovators to develop business models and commercialization plans for the technologies and to direct UK OTC's resources to maximize the long-term impact of each UK intellectual property (IP) asset.

Previously, Holly was the Deputy Director of the University of Louisville's technology transfer office, the Commercialization EPI-Center. She helped direct the office and managed new health-related UofL innovations, which involved intellectual property protection, technology marketing, license negotiation, and commercialization. She was also a Senior Technology Transfer Specialist at the National Cancer Institute. Holly has a B.S. in biology/genetics from the University of Maryland and a Ph.D. in molecular biology from the University of Pittsburgh.